https://www.selleckchem.com/pr....oducts/fenebrutinib-
0 months (95% confidence interval [CI] 68.3-79.7). After propensity score-matching, 64 patients remained in each group. The recurrence-free survivals were significantly longer in patients with glucocorticoids than in those without (full cohort median 12.0 months [95% CI 6.0-28.0] vs 6.9 months [4.2-17.0], P0.001; matched cohort median 12.0 months [95% CI 5.8-26.3] vs 8.3 months [4.3-18.2], P=0.015). After correction for confounding factors, perioperative glucocorticoids were significantly associated with prolonged recu
Beğen
Yorum Yap
Paylaş
